Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when CRIS files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: CRIS CURIS INC 8-K

Curis reports Q1 2026 financial results

Filed May 12, 2026 · Period ending May 12, 2026 · ~1 min read

2 key changes 1 high relevance 2 sections

Key Changes

  • high

    Curis announced financial results for the three months ended March 31, 2026. Detailed figures are in the attached press release (Exhibit 99.1), not in the 8-K body itself.

  • medium

    The 8-K filing serves as a routine wrapper for the earnings press release dated May 12, 2026. Investors should review the full press release for revenue, expenses, and cash position details.

    8-K: Exhibits verify on EDGAR →

Summary

Curis filed an 8-K on May 12, 2026, to announce its first-quarter 2026 financial results for the period ending March 31, 2026. This is a standard quarterly earnings disclosure. The 8-K itself contains minimal detail; the actual financial data—revenue, net loss, cash burn, and operational updates—are in the attached press release (Exhibit 99.1), which was not included in this filing body.

Retail investors should care because quarterly results reveal whether Curis is meeting its clinical development milestones, managing cash runway, and progressing toward commercialization of its oncology pipeline. Watch for the company's updated cash position and any guidance on how long current funds will last, as biotech firms often need additional capital raises that can dilute existing shareholders.

Section-by-Section Diff

Event · Item 2.02 — Results of Operations and Financial Condition

~100 words

Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.

1 Added
Added Q1 2026 financial results high

Added in current filing · verify on EDGAR →

On May 12, 2026, Curis, Inc. announced its financial results for the three-month periods ended March 31, 2026.

Curis disclosed its financial results for the first quarter of 2026 ending March 31, 2026. The actual financial data is contained in the press release attached as Exhibit 99.1, which is not included in this 8-K body.

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

Curis filed an 8-K attaching a press release dated May 12, 2026; no material business event disclosed in the filing body.

1 Added
Added Press release attachment medium

Added in current filing · verify on EDGAR →

Exhibit Number Description 99.1 Press Release dated May 12, 2026

The 8-K references an attached press release dated May 12, 2026 (Exhibit 99.1). The filing body itself contains no substantive disclosure about the press release content or the triggering event. Investors must review Exhibit 99.1 separately to understand what was announced.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · May 27, 2026 · How we verify